Mirshahidi S, Huang C T, Sadegh-Nasseri S
Department of Pathology, Johns Hopkins University, School of Medicine, Baltimore, MD 21205, USA.
J Exp Med. 2001 Sep 17;194(6):719-31. doi: 10.1084/jem.194.6.719.
Induction of tolerance in self-reactive memory T cells is an important process in the prevention of autoimmune responses against peripheral self-antigens in autoimmune diseases. Although naive T cells can readily be tolerized, memory T cells are less susceptible to tolerance induction. Recently, we demonstrated that low avidity engagement of T cell receptor (TCR) by low densities of agonist peptides induced anergy in T cell clones. Since memory T cells are more responsive to lower antigenic stimulation, we hypothesized that a low avidity TCR engagement may induce tolerance in memory T cells. We have explored two antigenic systems in two transgenic mouse models, and have tracked specific T cells that are primed and show memory phenotype. We demonstrate that memory CD4(+) T cells can be rendered anergic by presentation of low densities of agonist peptide-major histocompatibility complex complexes in vivo. We rule out other commonly accepted mechanisms for induction of T cell tolerance in vivo, such as deletion, ignorance, or immunosuppression. Anergy is the most likely mechanism because addition of interleukin 2-reversed anergy in specific T cells. Moreover, cytotoxic T lymphocyte antigen (CTLA)-4 plays a critical role in the induction of anergy because we observed that there was increased surface expression of CTLA-4 on anergized T cells, and that injection of anti-CTLA-4 blocking antibody restored anergy in vivo.
诱导自身反应性记忆T细胞产生耐受性是预防自身免疫性疾病中针对外周自身抗原的自身免疫反应的重要过程。尽管初始T细胞很容易产生耐受性,但记忆T细胞对耐受性诱导的敏感性较低。最近,我们证明了低密度激动剂肽对T细胞受体(TCR)的低亲和力结合可诱导T细胞克隆失能。由于记忆T细胞对较低的抗原刺激更敏感,我们推测低亲和力的TCR结合可能诱导记忆T细胞产生耐受性。我们在两种转基因小鼠模型中探索了两种抗原系统,并追踪了已致敏并呈现记忆表型的特异性T细胞。我们证明,在体内呈现低密度的激动剂肽-主要组织相容性复合体复合物可使记忆性CD4(+) T细胞失能。我们排除了体内诱导T细胞耐受性的其他普遍接受的机制,如细胞凋亡、忽视或免疫抑制。失能是最可能的机制,因为添加白细胞介素2可逆转特异性T细胞的失能。此外,细胞毒性T淋巴细胞抗原(CTLA)-4在失能诱导中起关键作用,因为我们观察到失能T细胞表面CTLA-4的表达增加,并且注射抗CTLA-4阻断抗体可在体内恢复失能状态。